Kyverna Share Price

Kyverna Share Price

NASDAQ: KYTX | Micro Cap | Healthcare
$4.38
-$0.10 (-2.23%) Last updated on 20 Nov, 2026 | 02:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Kyverna Stock Performance

Open
$4.57
Prev. Close
$4.48
Circuit Range
N/A
Day Range
$4.31 - $4.61
Year Range
$4.31 - $13.60
Volume
30,323
Average Traded
$4.40

Kyverna Share Price Today

As of 20 November 2026, Kyverna Therapeutics, Inc.'s share price is $4.38. The stock opened at $4.57, compared to its previous close of $4.48. During today's trading session, Kyverna Therapeutics, Inc.'s share price traded between $4.31 and $4.61, with an average price of $4.46. Over the past 52 weeks, the stock has recorded a high of $13.60 and a low of $4.31. In terms of performance, Kyverna Therapeutics, Inc.'s share price has declined by 48.50% over the last six months and is down 43.12% on a year-on-year basis.

Kyverna Share Price Chart

Line chart of the Kyverna price trend over the selected period. The price fell overall, ranging from 4.41 to 4.74, ending at 4.49.
$4.31$4.61
L
Show Current Price
H

Kyverna Stock Fundamentals & Key Indicators

Market Cap
$193.86M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.50
Revenue (TTM)
$0.00
Return On Equity (TTM)
-118.50%
Profit Margin
N/A
Debt to Equity
0.19
Quarterly Earnings Growth YoY
-10.95%

Kyverna Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.80-$39.73-$38.32-$41.94
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.11%3.55%-9.45%

Kyverna Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$127.48-$161.31
Net Profit MarginN/AN/A
Income ChangeN/A-26.54%

Kyverna Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets10.8714.04
Current Assets282.95290.6
Total Assets293.83304.65
Non Current Liabilities25.064.3
Current Liabilities36.4933.76
Total Liabilities61.5538.06
Shareholders' Equity232.28266.59

Kyverna Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-153.71-114.25
Investing40.02-160.9
Financing141.17337.11

About Kyverna

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Kyverna Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.83
$4.38
-22.63%
Oct 2026
$6.74
$5.66
-17.14%
Sep 2026
$8.28
$6.83
-20.96%
Aug 2026
$7.30
$8.63
+18.29%
Jul 2026
$8.91
$7.30
-17.98%
Jun 2026
$8.46
$8.90
+4.64%
May 2026
$8.77
$8.51
-3.68%
Apr 2026
$8.66
$8.83
+2.08%
Mar 2026
$7.88
$8.65
+5.23%
Feb 2026
$7.91
$8.22
+2.62%
Jan 2026
$9.46
$8.01
-14.61%
Dec 2025
$7.38
$9.38
+21.82%

Kyverna Share Price FAQs